Dr Bernadette Mc Guinness M.D., M.R.C.P.
Contact Details
|
 |
Biography:
| Bernadette McGuinness graduated in medicine from Queen’s University Belfast in 1997. She trained in geriatric medicine and general internal medicine, completing specialty training in 2007. During this time she graduated with MD for work on neuropsychological changes in Alzheimer’s disease and vascular dementia. Dr McGuinness was awarded the Paul Beeson Career Development Award in 2007, a prestigious award from Atlantic Philanthropies and the American Federation of Aging Research. This afforded three further years of research into mild cognitive impairment. She is lead author of 3 Cochrane reviews and lead/co-author of more than 30 peer-reviewed journal articles. She was appointed Senior Lecturer in Geriatric Medicine in NUIG and Consultant Geriatrician University Hospital Galway in 2010. Her research interests include technology and aging, dementia and falls. She is PI in a FP7 funded project ‘Wireless Insole for Independent Safe Elderly Living’ which commenced in 2011. She has established Galway Connected Health, a research centre containing 7 PIs interested in the area of connected health.She is also module lead for geriatric medicine taught in year 3.2 of undergraduate medicine. |
Peer Reviewed Journals
| Carrasquillo MM, Belbin O, Zou F, Allen M, Ertekin-Taner N, Ansari M, Wilcox SL, Kashino MR, Ma L, Younkin LH, Younkin SG, Younkin CS, Dincman TA, Howard ME,Howell CC, Stanton CM, Watson CM, Crump M, Vitart V, Hayward C, Hastie ND, Rudan I, Campbell H, Polasek O, Brown K, Passmore P, Craig D, McGuinness B, Todd S,Kehoe PG, Mann DM, Smith AD, Beaumont H, Warden D, Holmes C, Heun R, Kölsch H,Kalsheker N, Pankratz VS, Dickson DW, Graff-Radford NR, Petersen RC, Wright AF,Younkin SG, Morgan K. (2010) 'Concordant association of insulin degrading enzyme gene(IDE) variants with IDE mRNA, Abeta, and Alzheimer's disease'. PLoS One, 19 (5):1-E8764. [DOI] [Details] |
| McGuinness B, O'Hare J, Craig D, Bullock R, Malouf R, Passmore P. (2010) 'Statins for the treatment of dementia'. Cochrane Database Syst Rev. CD007514.Review, 4 (8). [DOI] [Details] |
| McGuinness B, Barrett SL, Craig D, Lawson J, Passmore AP. (2010) 'Executive functioning in Alzheimer's disease and vascular dementia'. Int J Geriatr Psychiatry, 25 (6):562-568. [DOI] [Details] |
| Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R, Gerrish A, Pahwa JS, Jones N, Stretton A, Morgan AR, Lovestone S, Powell J, Proitsi P, Lupton MK, Brayne C, Rubinsztein DC, Gill M, Lawlor B, Lynch A, Morgan K, Brown KS, Passmore PA, Craig D, McGuinness B, Todd S, Holmes C, Mann D, Smith AD, Love S, Kehoe PG, Mead S, Fox N, Rossor M, Collinge J, Maier W, Jessen F, Schürmann B, van den Bussche H, Heuser I, Peters O, Kornhuber J, Wiltfang J, Dichgans M, Frölich L, Hampel H, Hüll M, Rujescu D, Goate AM, Kauwe JS, Cruchaga C, Nowotny P, Morris JC, Mayo K, Livingston G, Bass NJ, Gurling H, McQuillin A, Gwilliam R, Deloukas P, Al-Chalabi A, Shaw CE, Singleton AB, Guerreiro R, Mühleisen TW, Nöthen MM, Moebus S, Jöckel KH, Klopp N, Wichmann HE, Rüther E, Carrasquillo MM, Pankratz VS, Younkin SG, Hardy J,O'Donovan MC, Owen MJ, Williams J. (2010) 'Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease'. PLoS One, 5 (11). [DOI] [Details] |
| Todd S, McGuinness B, Passmore AP (2010) 'Designing appropriate clinical trials to assess ACEI use and cognitive decline in older adults with hypertension'. Arch Intern Med, 170 (1). [DOI] [Details] |
| McGuinness B, Barrett SL, Craig D, Lawson J, Passmore AP. (2010) 'Attention deficits in Alzheimer's disease and vascular dementia'. J Neurol Neurosurg Psychiatry, 81 (2):157-159. [DOI] [Details] |
| McGuinness B, Passmore P. (2010) 'Can statins prevent or help treat Alzheimer's disease?'. J Alzheimers Dis, 20 (3):925-933. [DOI] [Details] |